Filed under: Ion Channel | Tagged: Adlea, agonist, ALGRX-4975, Anesiva, phase II, TRPV1, Vanilloid, VR1
Phase II trials of Adlea in post orthopedic surgery pain to take place in South Korea
Posted on June 3, 2008 by crimsoncanary
Tags
agonist amitiza Amlodipine Anesiva Angiotensin II AT1 antagonist AstraZeneca ca channel Calcium Channel chloride channel CIC-2 CIC2 cl channel Clevelox Clevidipine Cleviprex CV therapeutics Icagen Ion Channel KCa3.1 K Channel Licensing lidocaine lubiprostone Merck na channel Novartis phase II Potassium Channel preclinical Regulatory Research RU-0211 RU0211 Senicapoc Sodium channel SPI-0211 Sucampo takeda The Medicines Company TRPV1 UCB Vanilloid voltage gated VR1
Leave a Reply
Calendar
Blogroll
Blog at WordPress.com. Theme: Digg 3 Column by WP Designer
